Reply
Retina
.
2021 Sep 1;41(9):e56-e58.
doi: 10.1097/IAE.0000000000003183.
Authors
Jeffrey S Heier
1
,
Rishi P Singh
2
,
Charles C Wykoff
3
,
Karl G Csaky
4
,
Timothy Y Y Lai
5
,
Anat Loewenstein
1
,
Patricio G Schlottmann
6
,
Liliana P Paris
7
,
Peter D Westenskow
7
,
Carlos Quezada-Ruiz
8
9
Affiliations
1
Ophthalmic Consultants of Boston, Boston, Massachusetts.
2
Department of Ophthalmology, Center for Ophthalmic Bioinformatics, Cleveland Clinic, Cleveland, Ohio.
3
Retina Consultants of Texas, Retina Consultants of America, Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas.
4
Retina Foundation of the Southwest, Dallas, Texas.
5
Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Hong Kong.
6
Organizacion Medica de Investigacion, Buenos Aires, Argentina.
7
F. Hoffmann-La Roche Ltd., Basel, Switzerland.
8
Genentech, Inc., South San Francisco, California.
9
Retina y Vitreo, Clínica de Ojos Garza Viejo, San Pedro Garza Garcia, Mexico.
PMID:
34432748
DOI:
10.1097/IAE.0000000000003183
No abstract available
Publication types
Letter
Comment